120 related articles for article (PubMed ID: 16276347)
1. Enhanced suppression of tumor growth using a combination of NK4 plasmid DNA-PEG engrafted cationized dextran complex and ultrasound irradiation.
Hosseinkhani H; Kushibiki T; Matsumoto K; Nakamura T; Tabata Y
Cancer Gene Ther; 2006 May; 13(5):479-89. PubMed ID: 16276347
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound enhances in vivo tumor expression of plasmid DNA by PEG-introduced cationized dextran.
Hosseinkhani H; Tabata Y
J Control Release; 2005 Nov; 108(2-3):540-56. PubMed ID: 16219383
[TBL] [Abstract][Full Text] [Related]
3. Suppression of the progress of disseminated pancreatic cancer cells by NK4 plasmid DNA released from cationized gelatin microspheres.
Kushibiki T; Matsumoto K; Nakamura T; Tabata Y
Pharm Res; 2004 Jul; 21(7):1109-18. PubMed ID: 15290849
[TBL] [Abstract][Full Text] [Related]
4. Suppression of tumor metastasis by NK4 plasmid DNA released from cationized gelatin.
Kushibiki T; Matsumoto K; Nakamura T; Tabata Y
Gene Ther; 2004 Aug; 11(15):1205-14. PubMed ID: 15103321
[TBL] [Abstract][Full Text] [Related]
5. PEGylation enhances tumor targeting of plasmid DNA by an artificial cationized protein with repeated RGD sequences, Pronectin.
Hosseinkhani H; Tabata Y
J Control Release; 2004 May; 97(1):157-71. PubMed ID: 15147813
[TBL] [Abstract][Full Text] [Related]
6. Augmented anti-tumor therapy through natural targetability of macrophages genetically engineered by NK4 plasmid DNA.
Okasora T; Jo JI; Tabata Y
Gene Ther; 2008 Apr; 15(7):524-30. PubMed ID: 18239606
[TBL] [Abstract][Full Text] [Related]
7. Systemic NK4 gene therapy inhibits tumor growth and metastasis of melanoma and lung carcinoma in syngeneic mouse tumor models.
Kishi Y; Kuba K; Nakamura T; Wen J; Suzuki Y; Mizuno S; Nukiwa T; Matsumoto K; Nakamura T
Cancer Sci; 2009 Jul; 100(7):1351-8. PubMed ID: 19438869
[TBL] [Abstract][Full Text] [Related]
8. Liver targeting of plasmid DNA with a cationized pullulan for tumor suppression.
Jo J; Yamamoto M; Matsumoto K; Nakamura T; Tabata Y
J Nanosci Nanotechnol; 2006; 6(9-10):2853-9. PubMed ID: 17048491
[TBL] [Abstract][Full Text] [Related]
9. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
Kuba K; Matsumoto K; Date K; Shimura H; Tanaka M; Nakamura T
Cancer Res; 2000 Dec; 60(23):6737-43. PubMed ID: 11118060
[TBL] [Abstract][Full Text] [Related]
10. Retraction Note: Enhanced suppression of tumor growth using a combination of NK4 plasmid DNA-PEG engrafted cationized dextran complex and ultrasound irradiation.
Hosseinkhani H; Kushibiki T; Matsumoto K; Nakamura T; Tabata Y
Cancer Gene Ther; 2020 Apr; 27(3-4):266. PubMed ID: 31664167
[TBL] [Abstract][Full Text] [Related]
11. Ultrasound enhancement of in vitro transfection of plasmid DNA by a cationized gelatin.
Hosseinkhani H; Aoyama T; Ogawa O; Tabata Y
J Drug Target; 2002 May; 10(3):193-204. PubMed ID: 12075820
[TBL] [Abstract][Full Text] [Related]
12. NK4 gene therapy targeting HGF-Met and angiogenesis.
Matsumoto K; Nakamura T
Front Biosci; 2008 Jan; 13():1943-51. PubMed ID: 17981681
[TBL] [Abstract][Full Text] [Related]
13. Preparation of poly(ethylene glycol)-introduced cationized gelatin as a non-viral gene carrier.
Kushibiki T; Tabata Y
J Biomater Sci Polym Ed; 2005; 16(11):1447-61. PubMed ID: 16370244
[TBL] [Abstract][Full Text] [Related]
14. Tumor suppression through angiogenesis inhibition by SUIT-2 pancreatic cancer cells genetically engineered to secrete NK4.
Saimura M; Nagai E; Mizumoto K; Maehara N; Minamishima YA; Katano M; Matsumoto K; Nakamura T; Tanaka M
Clin Cancer Res; 2002 Oct; 8(10):3243-9. PubMed ID: 12374695
[TBL] [Abstract][Full Text] [Related]
15. Suppression of human colon tumor growth by adenoviral vector-mediated NK4 expression in an athymic mouse model.
Jie JZ; Wang JW; Qu JG; Hung T
World J Gastroenterol; 2007 Apr; 13(13):1938-46. PubMed ID: 17461494
[TBL] [Abstract][Full Text] [Related]
16. Effect of amine type on the expression of plasmid DNA by cationized dextran.
Jo J; Nagane K; Yamamoto M; Tabata Y
J Biomater Sci Polym Ed; 2010; 21(2):225-36. PubMed ID: 20092686
[TBL] [Abstract][Full Text] [Related]
17. Hepatic gene expression of NK4, an HGF-antagonist/angiogenesis inhibitor, suppresses liver metastasis and invasive growth of colon cancer in mice.
Wen J; Matsumoto K; Taniura N; Tomioka D; Nakamura T
Cancer Gene Ther; 2004 Jun; 11(6):419-30. PubMed ID: 15017381
[TBL] [Abstract][Full Text] [Related]
18. Targeting angiogenesis and HGF function using an adenoviral vector expressing the HGF antagonist NK4 for cancer therapy.
Maemondo M; Narumi K; Saijo Y; Usui K; Tahara M; Tazawa R; Hagiwara K; Matsumoto K; Nakamura T; Nukiwa T
Mol Ther; 2002 Feb; 5(2):177-85. PubMed ID: 11829525
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of mesothelioma cancer stem-like cells with adenovirus-mediated NK4 gene therapy.
Deng XB; Xiao L; Wu Y; Jin F; Mossman B; Testa JR; Xiao GH
Int J Cancer; 2015 Jul; 137(2):481-90. PubMed ID: 25501304
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem cell-based NK4 gene therapy in nude mice bearing gastric cancer xenografts.
Zhu Y; Cheng M; Yang Z; Zeng CY; Chen J; Xie Y; Luo SW; Zhang KH; Zhou SF; Lu NH
Drug Des Devel Ther; 2014; 8():2449-62. PubMed ID: 25525335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
